Search for: "BIOGEN INC." Results 41 - 60 of 259
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2022, 12:00 pm by Gerry W. Beyer
A phase III clinical trial that published results earlier this week in the New England Journal of Medicine shows promising data that Alzheimer’s drug, Lecanemab by Eisai and Biogen Inc, can slow cognitive decline. [read post]
25 Jun 2021, 4:15 am by Logan Murr
A group of intellectual property professors; GlaxoSmithKline plc; and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
1 Feb 2008, 1:24 am
According to the IP Kat reporting on Glaxo Group Ltd v Genentech Inc and Biogen Idec Inc. [2008] EWCA Civ 23, the UK Court of Appeal confirmed the Patent Court's decision to permit a British national invalidity proceeding to go forward without suspension, despite the existence of a parallel opposition proceeding at the EPO. [read post]
9 Aug 2009, 12:44 am
Biogen IDEC, 304 F.App'x 866 (Fed. [read post]
7 Jan 2010, 10:56 am by Mark Zamora
Biogen Idec Inc (BIIB.O) said on Wednesday that four more patients taking its multiple sclerosis drug Tysabri had developed a potentially deadly brain infection known as PML in November, bringing the total to 28. [read post]
6 Nov 2017, 9:38 pm by Patent Docs
Biogen, Inc and Genentech, Inc. [read post]
17 Feb 2016, 12:19 am
Always a fan of a case management decision, the AmeriKat was interested to see the decision in Celltrion Inc. v Biogen Idec Inc., F. [read post]
2 Jan 2024, 9:34 am by Lyle Roberts
Biogen, Inc., 84 F.4th 1 (1st Cir. 2023), the court considered this question in a case involving a drug study and the FDA approval process. [read post]
7 Aug 2008, 8:16 pm
Biogen Idec Inc., No. 07-2626 affirms the dismissal of a Private Securities Litigation Reform Act of 1995 ("PSLRA"), Pub. [read post]
17 Aug 2010, 9:52 pm by Patent Docs
Biogen Idec, and Association for Molecular Pathology v. [read post]